SUBSCRIBE: Print / eNewsletter
With the growing number of cancer survivors, there is increased interest in understanding and preventing post-treatment sequelae that may limit full recovery to prediagnosis health.
Breast cancer treatments today are likely to cause less physical deformity from surgery than a half-century ago, but are more complex and extend over a longer period of time. Women today are often well informed about the details of their cancer diagnosis and prognosis, and are increasingly involved in shared decision-making regarding treatment.
This paper reviews the current status of translation of quality of life outcomes from research to clinical practice. A major barrier in this process is the lack of mature results from quality of life studies in phase III randomized controlled trials. As more trials are completed, we can expect the diffusion of those results into clinical practice and decision making. Further, as quality of life measurement tools are used more widely and become more user-friendly, we can anticipate their adoption in the routine clinical assessment of patients in the oncologist's practice. [ONCOLOGY 9(Suppl):61-65, 1995]
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
